dMY Technology filed an amended proxy on its proposed merger with Rush Street Interactive. The deal values the combined company at an enterprise value of $1.78 billion, which is 5.6 times Rush Street’s projected 2021 revenue of $320 million. Read more.
Related Posts
H.I.G. Acquisition II Files for
H.I.G. II is targeting the technology, media, telecommunications (“TMT”) or healthcare sectors.
Virgin Group Acquisition III Withdraws $300M IPO
The SPAC had planned to focus on branded businesses.
Social Capital Suvretta Holdings III Files Proxy on $2.64B ProKidney Deal
The transaction is expected to deliver up to $825 million to ProKidney, including the contribution of up to $250 million of cash held in the SPAC's trust, less any redemptions, and a fully committed PIPE of $575 million.
Humacyte Going Public via $275M Merger with Alpha Healthcare
At closing, Humacyte is expected to have a market capitalization of $1.1 billion.